Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06619093
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-26
Brief Title:
Relationship Between Biological Phenotype Clinical Severity of Sickle Cell Disease and Blood Coagulation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Relationship Between Biological Phenotype Clinical Severity of Sickle Cell Disease and Blood Coagulation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DREPA COAG
Brief Summary:
Sickle cell disease is characterized by chronic hemolytic anemia and blood rheological alterations In addition blood coagulation abnormalities have been reported in patients with sickle cell disease and hemolysis-derived products could be involved The investigators hypothesized that patients with sickle cell disease and severe hemolysis Lactate Dehydrogenase level gt 484 IUL could have an increased risk of hypercoagulable state and subsequent thromboembolic complications
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None